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Abstract
A variety of studies have demonstrated that motor disor-
ders, parkinsonism and extrapyramidal motor symp-
toms (EPMS) are common in patients with Alzheimer’s
disease (AD). Several studies have reported an associa-
tion of EPMS with severity, progression and poor prog-
nosis of AD. The majority of these studies used clinical
assessments for the rating of EPMS. In this study, kine-
matic handwriting analysis was used to quantify differ-
ences in fine hand motor function in patients with proba-
ble AD and mild cognitive impairment (MCI, as an
assumed initial stage of AD) compared to depressed
patients and healthy controls. Both patients with MCI
and patients with probable AD exhibited loss of fine
motor performance. Movements of AD patients were sig-
nificantly less regular than those of healthy controls.
Copyright © 2003 S. Karger AG, Basel
Introduction
Since Western society is facing the perspective of a
growing elderly population with increasing numbers of
patients with Alzheimer’s disease (AD), improvement in
the diagnosis of very early and, if possible, preclinical
phases of AD is required. Since no single marker of AD
exists, the diagnosis of dementia, AD and other diseases
leading to dementia (for instance Lewy body dementia,
LBD) is a decision based on multiple sources of informa-
tion that are considered simultaneously.
The dominant feature of AD is the progressive decline
of cognition, especially mnestic functions and orientation.
Though impaired cognitive functions can be observed
even in preclinical stages of AD [1], age-related impair-
ments in mnestic functions can be observed in all subjects
of this age group [2–4].
Hence other indicators for the detection of people who
are at high risk for developing AD are necessary. In this
context, the assessment of motor functions has become of
increasing interest for mainly three reasons: (1) for the
early diagnosis of AD, (2) as a possible predictor of the
progression of the disease and (3) for the diagnostic differ-
entiation between AD and other forms of dementia, e.g.
LBD.
Neurological symptoms are no diagnostic criteria for
the diagnosis of AD, but starting with the first report of
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Pearce in 1974 [5], who found extrapyramidal features of
parkinsonian type in 40 out of 65 patients, growing atten-
tion has been paid to the role of extrapyramidal signs and
other motor dysfunction in the course of AD [6]. A variety
of studies have demonstrated that parkinsonism and ex-
trapyramidal motor symptoms (EPMS) are common in
patients with AD, the reported prevalence of EPMS
ranges between 6 and 92% [7–11]. Motor dysfunction
occurs even in mildly demented AD patients without
EPMS [12]. EPMS seem to be apparent already in initial
stages of AD, and several studies have reported an asso-
ciation between EPMS and AD severity, progression,
functional decline, poor prognosis and mortality [13–19].
The existence of EPMS in AD patients gained impor-
tance in view of the discussion of LBD and the Lewy body
variant of AD [20]. While a number of studies reported a
higher incidence of parkinsonism and EPMS and a faster
cognitive decline in these patients [21–24], other studies
found no specific clinical symptoms [25–27].
The majority of these studies used clinical examina-
tions or standardized clinical rating scales, like the Abnor-
mal Involuntary Movement Scale or the Unified Parkin-
son’s Disease Rating Scale, to examine the presence of
EPMS. Standardized neuropsychological tests were used
to assess severity and nature of cognitive and psychomo-
tor dysfunction like aphasia, apraxia, agnosia and execu-
tive function disorders [28].
Only few studies applied quantitative instrumental
methods to measure EPMS [29–35]. Instrumental mea-
surement has two methodological advantages compared
with rating scales: (1) instrumental tests allow an objec-
tive and repeatable measurement of symptoms and may
even reveal subtle and subclinical motor abnormalities
that are below the threshold of clinical detection. In rating
scales, the registration of symptoms depends on the clini-
cal impression of the rater. Therefore the reliability, espe-
cially in longitudinal and multicenter studies, depends on
good interrater and intrarater reliability, respectively. Ri-
chards et al. [36] reported problems with the recognition
and conformity of mild and subclinical subtle symptoms.
(2) Instrumental tests allow a linear measurement of the
severity of symptoms on a continuous interval scale. In
rating scales, the registration of symptoms and therefore
the statistical analysis of data is restricted to a discontin-
uous nominal or ordinal scale.
Another approach for the measurement and analysis of
motor dysfunction is the quantification of kinematic
handwriting movements using a digitizing tablet [37].
Besides the measurement of velocity and acceleration,
this method allows exact statements on the quality or
automation and accuracy of handwriting movements. Ki-
nematic handwriting analysis has been proven to be a val-
id method to detect even subtle motor abnormalities in
several studies with schizophrenic patients [38, 39] and
patients with obsessive-compulsive disorder [40]. Kine-
matics of handwriting has also be shown to be a valid
measure of dysfunction of the extrapyramidal system. It
reflects motor abnormalities in patients with Parkinson’s
disease (PD) in a very sensitive way, especially bradykine-
sia [41] and micrographia [42]; similarly, subclinical dis-
turbances of the extrapyramidal system in patients with
other basal ganglia disease (e.g. Huntington’s disease)
could be exactly measured using kinematic handwriting
analysis [43]. Slavin et al. [34] used a similar method in a
comparative analysis of handwriting movements in AD
patients, Huntington’s disease and PD patients, and
healthy controls (HCs).
In the present study, kinematic handwriting analysis
was used to compare quantified fine hand motor function
in patients with probable AD and mild cognitive impair-
ment (MCI, as an assumed initial stage of AD) with that
of patients with the diagnosis of a major depression
(DEPs) and HCs. Major depression represents a relevant
differential diagnosis of AD. Moreover, extrapyramidal
disturbances (especially psychomotor retardation resem-
bling that in patients with PD) could also be objectified in
patients with depression [44], and several studies suggest
that basal ganglia dysfunction represents a relevant factor
in the pathophysiology of depression [45]. Sabbe et al.
[46] could demonstrate that psychomotor retardation in
depression (suggesting basal ganglia dysfunction) has a
cognitive component, since motor differences between
depressed patients and healthy controls increase with task
complexity. Therefore it will be interesting to address the
question whether AD patients can be differentiated from
elderly DEPs by using kinematic handwriting parame-
ters.
Above all, the main aim of this study was to examine
whether the kinematic analysis of hand-motor dysfunc-
tion in even subclinical intensity can be used to differen-
tiate between AD, MCI and depression in the elderly. On
the basis of the literature cited above we formulated the
following hypotheses:
(1) AD and MCI patients exhibit a lower degree of
automation and regularity of handwriting movements
than DEPs and HCs.
(2) The severity of motor symptoms in AD patients is
correlated with lower automation and regularity of hand-
writing movements.
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Table 1. Clinical characteristics of patients
and controls AD MCI DEP HC p
Participants 35 39 39 40
Gender (f/m) 17/18 23/16 30/9 23/17 n.s.
Age, years 70.6B11.2 60.6B11,1 60.2B8.7 65.6B7.9 0.000
MMSE score 21.3B2.9 27.8B1.7 27.2B2.2 29.3B0.7 0.000
Severity of dementia 0.000
MMSE 15–17 6 – – –
MMSE 18–22 16 – 2 –
MMSE 23–30 13 39 37 40
Age and MMSE scores are means B SD
Table 2. Summary of writing habits
AD MCI DEP HC p
Edinburgh score 84.1B30.4 90.3B30.8 83.7B33.7 88.4B30.7 n.s.
Writing hand (r/l) 35/– 38/1 39/– 40/– n.s.
Frequency of writing/day 0.011
!10 min/day 29 23 28 23
10–20 min/day 1 1 3 8
120 min/day 5 15 8 9
Edinburgh scores are means B SD, all other scores reflect actual numbers.
Materials and Methods
Patients and Controls
A sample was selected from all patients (n = 173) admitted to the
outpatient clinic for memory disorders (‘Gedächtnissprechstunde’)
at the Department of Psychiatry of the Ludwig Maximilians Univer-
sity, Munich, on the basis of the following criteria:
E diagnosis of probable AD according to the NINCDS-ADRDA
criteria for dementia [47],
E diagnosis of MCI according to the criteria for MCI of Petersen et
al [48] and
E diagnosis of major depression according to DSM-III-R criteria
[49].
We excluded all patients with a history or current clinical evi-
dence of a stroke or any other additional organic condition that could
adversely affect cognition or motor function. Cognitive function was
examined using the ‘Mini Mental State Examination’ (MMSE) [50].
Only patients with mild or moderate cognitive disturbances (MMSE
score above 15) were included in the study.
Since the literature suggests that there is a higher risk for older
patients to develop acute and subacute extrapyramidal side effects
under neuroleptic treatment even with very low doses [51, 52],
patients with neuroleptic or lithium treatment were excluded from
further analysis. Psychotropic medication included antidepressants
(tricyclic and tetracyclic antidepressants, TTA, and selective seroton-
in re-uptake inhibitors, SSRI), nootropics and acetylcholinesterase
inhibitors.
After a complete description of the study, written informed con-
sent was obtained from all participants. Kinematic analysis of hand-
writing movements, using a digitizing tablet, a questionnaire on writ-
ing habits and the ‘Edinburgh Handedness Inventory’ (EHI) [53],
were obtained from 35 patients with probable AD, 39 patients with
the diagnosis of MCI and 21 patients with a diagnosis of depression.
Additionally, 18 elderly medicated depressive inpatients and 40
elderly healthy controls with an age above 55 years were examined.
The clinical characteristics of the patients and controls are shown
in table 1. Summaries of the writing habits and of medications cur-
rently prescribed for all participants are shown in tables 2 and 3.
Apparatus
Handwriting movements were recorded using a commercial
WACOM-IV digitizing tablet and a pressure-sensitive stylus. All par-
ticipants wrote with the inking stylus on a paper fastened to the digi-
tizing tablet. The x-y-coordinates of the stylus tip position on the dig-
itizing tablet were recorded with a sampling rate of maximal 200 Hz
and a spatial resolution of 0.05 mm, and concurrently transmitted to
a personal computer interface.
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Table 3. Summary of medications currently prescribed
AD MCI DEP HC
No medication 16 31 13 32
Psychotropic medication
Antidepressants 3 1 13 –
SSRI 3 1 4 –
Tri-/tetracyclic – – 9 –
Nootropics 6 2 2 –
Combination of antidepressants
and nootropics 2 – 1 –
Benzodiazepine – 1 – –
Other medication 8 4 10 8
Tasks and Procedure
Participants were seated on a chair with the digitizing tablet
placed on a desk in front of them. All participants were given the
possibility to adjust the height of the chair and the position of the
digitizing tablet. All participants were instructed to perform two
movement tasks. Task 1 meant drawing concentric superimposed
circles of 12 mm in diameter as fast and fluently as possible with their
dominant hand for 30 s; task 2 asked the participants to draw concen-
tric superimposed circles of 12 mm in diameter as fast and fluently as
possible with their dominant hand while simultaneously performing
an additional distraction task (pressing a counting device as often as
possible) with the nondominant hand for 10 s.
Both tasks were initially demonstrated to the participants. After-
wards all participants were given the opportunity to practice until
they were familiar with the procedure. If necessary, patients were
reminded of the task or were given additional demonstrations.
Kinematic Handwriting Analysis
Subsequent standardized kinematic handwriting analysis of the
y-coordinate’s writing movements was performed with the software
‘CS 4.3’ [54]. The program segments handwriting motions into half
circles (called ‘strokes’) corresponding to the vertical up and down
movements. A stroke is defined by two sequential extrema of maxi-
mum or minimum curvature. These transition points correspond to
changes in direction and therefore to a minimum velocity of 0. Auto-
mated hand movements are characterized by single peaked, bell-
shaped velocity profiles of the strokes.
With CS 4.3 the mean peak velocity (V, the arithmetical mean of
the velocity peaks of all strokes) and V-SD (the standard deviation of
the intraindividual velocity profile) were calculated. The writing fre-
quency (Freq), i.e. the number of strokes per second, was also calcu-
lated.
Non-parametric kernel estimates [37] were used to calculate a
parameter for the automation of the movement (NCV = number of
changes of direction of velocity), a parameter of the smoothness of
the handwriting movement. As mentioned above, automation for a
single stroke is assumed to go along with an ideal NCV value of 1. In
figure 1, the concept of segmentation and automation is demon-
strated by an example of an AD patient (female, 72 years old, NCV =
5.41) and a matched healthy control (NCV = 1.27).
Furthermore, the relative velocity (V-Rel), as a measure of the
proportion of the intraindividual (V-SD) to the individual peak
velocity (V), was calculated by dividing the mean peak velocity V by
its standard deviation V-SD.
Frequency and NCV are indicators of the automation of move-
ment, while both V-SD and V-Rel are indicators of the coordination
and regularity of movement sequences.
Statistical Design and Methods
All data were entered into a SPSS database for statistical analysis.
Comparisons of frequency data between patient groups were done
using ¯2 analyses. Between-group differences of age were explored
using one-way analyses of variance (ANOVA), between-group differ-
ences of the lateralization quotient of the EHI as well as the MMSE
score by use of Kruskal-Wallis tests. Spearman-Brown correlation
coefficients for all groups were calculated to explore possible relation-
ships between handwriting parameters, age and MMSE scores, since
some of these variables (MMSE scores, NCV, V-SD, V-Rel) were not
normally distributed (Kolmogorov-Smirnov test: p ^ 0.05). Other-
wise, in the case of normal distribution, Pearson’s correlation coeffi-
cients were computed.
Due to reports of SSRI- and acetylcholinesterase inhibitor-
induced extrapyramidal side effects [55–57], 3 medication groups
were formed to rule out possible effects of psychotropic medication
on kinematic handwriting performance (group 1: no medication,
group 2: psychotropic medication (antidepressants and/or nootro-
pics) and group 3: other medication). Due to the significant correla-
tion between age and kinematic parameters, kinematic parameters
were submitted as dependent variables to a 4 ! 3 univariate analyses
of covariance (ANCOVA, Bonferroni adjusted) design with ‘diagno-
sis’ (AD, MCI, major depression, HC) and ‘medication’ as between-
group factors controlled for ‘age’ as the covariate. Significant F statis-
tics were explored using post hoc ANCOVA. Despite the fact that
variances were unequal (Levene tests: p ^  0.05), the dependent vari-
ables were not transformed to homogenize variance because sample
sizes were at least n = 35 and almost equal (35 ^ n ^ 40), and
because it is well known that ANOVA is quite robust regarding heter-
ogeneity of variances if the compared groups are large enough (at
least n = 10) and if sample sizes are almost equal [58]. All hypothesis
tests were two-sided and statistical significance was set at p ^ 0.05.
Results
Sociodemographic and Clinical Characteristics and
Writing Habits
The one-way ANOVA revealed a significant effect of
age (F = 9.714; p = 0.000) and MMSE scores (¯2 = 94.73;
p = 0.000). Post hoc Scheffé tests displayed no significant
differences in age between MCI patients, DEPs and HCs,
while AD patients were significantly older than DEPs (p =
0.000) and MCI patients (p = 0.000). A ¯2 analysis for
gender showed no significant differences between all
groups (compare table 1). An analysis of the medications
currently prescribed showed that AD patients and DEPs
consumed significantly more medication, especially psy-
chotropic medication like antidepressants and/or nootro-
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Fig. 1. The concept of segmentation and automation: velocity and acceleration curves necessary to circles are
segmented into basal motor units (strokes). Based on this segmentation, kinematic parameters can be computed, e.g.
the NCV. Higher NCV values represent disturbances of handwriting automation. The ideal NCV score is 1. The
graph illustrates disturbances of hand drawing automation (NCV = 5.41) in an AD patient, compared with an HC
with a high degree of hand movement automation (NCV = 1.27); both probands are female and 72 years old.
NCV (AD patient)
NCV (healt y control)h
–61.4
71.7
[VY]
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–96.3
139.2
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5,000 1000 ms
pics, than MCI patients and HCs (¯2 = 41.11; p = 0.000;
table 3). All participants but 1 were right-handed. There
were no group differences for the lateralization quotient
of the EHI (¯2 = 5.70; p = 0.13). Results regarding the
frequency of handwriting per day (3 categories: under
10 min/day, 10–20 min/day, more than 20 min/day)
showed that especially AD patients wrote less than the
other groups (¯2 = 16.502; p = 0.011; table 2).
Differences in Kinematic Handwriting Parameters
between Patients and Healthy Controls
Univariate ANCOVA revealed significant effects of
age (for task 1: Freq, F = 11.227; p = 0.001; V-Rel, F =
13.969; p ^ 0.001; for task 2: Freq, F = 7.450; p = 0.007;
V-Rel, F = 3.932; p = 0.049; counting device, F = 15.591;
p ^ 0.001) and diagnosis (see below) on kinematic hand-
writing parameters in both task 1 and task 2. There was no
significant effect of medication or interaction between
diagnosis and medication.
Results of ANOVA for task 1 showed significant group
effects for velocity variation (V-SD, F = 4.072; p = 0.008)
and relative velocity (V-Rel, F = 3.132; p = 0.028). Fre-
quency, automation (NCV) and V did not significantly
differ between the four groups, peak velocity was even
slightly elevated in AD patients compared to healthy con-
trols. Post hoc ANCOVA revealed that both the individu-
al V-SD and the V-Rel were significantly increased in AD
patients compared to healthy controls (p = 0.004, p =
0.048; respectively). In addition, AD patients drew the
circles with significantly higher V-SD than depressed
patients (p = 0.033) and patients with MCI (p = 0.042).
Depressed patients were found to exhibit significantly
higher V-SD than did healthy subjects (p = 0.005).
ANOVA of the kinematic parameters for task 2 pre-
sented similar results. There were significant group effects
for V-Rel (F = 5.768; p = 0.001) and NCV (F = 3.011; p =
0.032). Again there was no significant difference in writ-
ing frequency, V and the intraindividual V-SD between
Handwriting Analysis in AD Dement Geriatr Cogn Disord 2003;15:132–142 137
Table 4. Summary of task 1
AD MCI DEP HC
Frequency, Hz 2.59B1.24 2.40B1.35 3.05B1.23 2.97B1.02
NCV 4.00B4.81 4.09B4.46 2.64B3.93 1.83B1.10
V, mm/s 118.63B82.26 101.63B52.31 114.28B49.38 102.38B34.74
V-SD, mm/s 23.68B14.77 16.44B9.76 17.38B7.26 15.21B7.62
V-Rel, % 22.08B11.92 17.08B6.64 16.08B5.60 14.71B4.22
Data are means B SD.
Table 5. Summary of task 2
AD MCI DEP HC
Frequency, Hz 2.73B1.35 2.62B1.45 3.10B1.22 3.41B0.90
NCV 3.54B4.54 3.37B3.34 2.21B2.27 1.41B0.63
V, mm/s 113.21B59.91 112.54B63.90 114.42B44.46 115.38B31.56
V-SD, mm/s 25.78B15.63 19.7B13.83 21.06B11.20 19.05B7.62
V-Rel, % 24.37B13.59 18.58B9.65 18.23B6.51 16.56B5.35
Counting device 21.97B10.57 26.97B11.80 27.31B11.61 32.35B7.68
Data are means B SD.
the four groups. There was also a significant effect for the
distraction task (F = 2.777; p = 0.044). Post hoc AN-
COVA revealed that the V-Rel in AD patients was signifi-
cantly higher compared with all other groups (MCI p =
0.033; DEP p = 0.043; HC p ^  0.001). Moreover, AD and
MCI patients drew circles with significantly higher NCV
than HCs (p = 0.024, p = 0.021; respectively). As to oper-
ating the counting device, HCs achieved a significantly
higher performance than AD patients (p = 0.012), DEPs
(p = 0.038) and MCI patients (p = 0.020). Summaries of
the results of both tasks are presented in table 4, 5.
Associations between the Severity of Cognitive Decline
and Kinematic Handwriting Parameters
Kolmogorov-Smirnov tests revealed that MMSE
scores, NCV, V-SD and V-Rel were not normally distrib-
uted. Thus Pearson correlation coefficients were calcu-
lated to explore possible associations between Freq, V and
age. Spearman-Brown correlation was calculated in order
to detect possible associations between kinematic param-
eters and MMSE scores. Analogously, this type of correla-
tion was used in order to explore associations between
NCV, V-SD, V-Rel and age.
Cognitive function was negatively correlated with age
(Spearman’s Ú = –0.129; p = 0.112). In both tasks, age was
significantly correlated with frequency (task 1: r = –0.247,
p = 0.002; task 2: r = –0.209, p = 0.01) and V-Rel (task 1:
Spearman’s Ú = 0.285, p = 0.000; task 2: Spearman’s Ú =
0.173, p = 0.035). Moreover, higher age was found to be
significantly associated with higher NCV for drawing cir-
cles without distraction (Spearman’s Ú = 0.226, p =
0.005).
Significant correlations were found in both tasks be-
tween cognitive function and kinematic handwriting pa-
rameters, reflecting poorer motor coordination in cogni-
tively impaired patients (fig. 2–5). Significant negative
correlations were found between MMSE score and NCV
(task 2: Spearman’s Ú = –0.190, p = 0.02), V-SD (task 1:
Spearman’s Ú = 0.223, p = 0.006) and V-Rel (task 1:
Spearman’s Ú = –0.226, p = 0.005; task 2: Spearman’s Ú =
–0.210; p = 0.01). Higher writing frequency, indicating
better automation, was significantly correlated with a
higher MMSE score in task 2 (r = 0.170, p = 0.038). Peak
velocity was not significantly correlated with MMSE
scores and age.
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Fig. 2. Scatterplots showing associations between frequency (mean number of half-circles drawn with the dominant
hand per second) under two task conditions (a without simultaneous pressing of a counting device with the nondomi-
nant hand; b with simultaneous pressing of this device) and total MMSE scores in 35 patients with probable AD, 39
patients with MCI, 39 DEPs and 40 HCs.
Fig. 3. Scatterplots showing associations between NCV (mean number of changes of direction of velocity per stroke
for fast drawing of superimposed concentric circles with the dominant hand) and MMSE scores in the same patients
and under the same conditions elaborated in figure 2.
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Fig. 4. Scatterplots showing associations between V-SD (standard deviation of the intraindividual velocity profile for
fast drawing of superimposed concentric circles with the dominant hand) and MMSE scores in the same patients and
under the same conditions elaborated in figure 2.
Fig. 5. Scatterplots showing associations between V-Rel (measure of the proportion of the intraindividual V-SD to the
individual peak velocity for fast drawing of superimposed concentric circles with the dominant hand) and MMSE
scores in the same patients and under the same conditions elaborated in figure 2.
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Discussion
The results of the present study demonstrate that quan-
titative kinematic handwriting parameters are related to
cognitive status in elderly patients. Patients with MCI and
patients with probable AD exhibited a loss of fine motor
performance. Especially when compared to HCs, move-
ments of AD patients were significantly less automated,
accurate and regular. These group differences in kinemat-
ic handwriting parameters persisted even after statistical-
ly controlling for age and medication.
Differentiation between patients with MCI and
healthy subjects increased with task complexity in task 2.
This underlines the findings of Kluger et al. [31], who
administered a comprehensive motor test battery, includ-
ing computer-based tests, to mild AD and MCI patients.
Compared to healthy controls, MCI patients performed
worse on tasks involving fine and complex motor func-
tion, while AD patients also exhibited motor dysfunction
even on tasks assessing gross motor control.
Medication had no effect on kinematic handwriting
performance in this study. However, the absence of a
medication effect should be interpreted with caution as
the lack of significance could be a reflection of the small
sample size, and hence the statistic may have been under-
powered. The strong effect of age is in line with findings of
other groups. Morgan et al. [59] reported on an age effect
upon abductive and adductive movements in a kinematic
analysis, with older healthy subjects exhibiting more
asymmetries and lower peak velocities than younger
healthy subjects. Bellgrove et al. [60] could demonstrate
that older adults produced slower and less efficient move-
ments. Using the same paradigm as in the present study,
Mergl et al. [61] showed an effect of age upon kinematic
handwriting parameters in healthy subjects, with younger
subjects exhibiting higher peak velocities and a higher
degree of automation than older subjects.
Although we found a significant age effect, the differ-
ences in kinematic handwriting parameters cannot be
explained merely on the basis of age, since MCI patients
exhibited poorer motor performance compared to healthy
subjects without a significant difference in age between
these groups.
It is possible that other conditions interfered with the
loss of fine motor performance in the patient groups, e.g.
PD. Hand movements and the generation of writing
movements are complex processes involving the integra-
tion of different instances, from planning to the activation
and execution of simple motor programs [62, 63]. Distur-
bances in any of these instances therefore result in dis-
turbed movement sequences. Yet motor skills, expressed
by mean peak velocity, were still intact in all participants,
indicating that the differences in fine motor performance
are an expression of concurrent cognitive impairment.
Since cognitive impairments, culminating in dementia
and depression, are among the most frequent and disa-
bling conditions in the elderly, there exists a high degree
of comorbidity between them. Reports on the prevalence
of depression in AD patients vary [64, 65]. Fichter et al.
[66] described an excess of comorbidity between cognitive
impairment and depression in very old people (aged 85
years and above). Schröder et al. [67] found that in MCI
patients complaints of cognitive deficits were significant-
ly correlated with higher scores on depression. Steffens et
al. [68] reported an association of cognitive impairment
with depression severity among older patients with unipo-
lar major depression. Significant correlations between
cognitive impairment, depression and neuropsychologic
test performance could be detected [2, 69]. Particularly
the clinically important differentiation between MCI, as
an assumed initial stage of dementia, and depression is
aggravated in elder patients. As MCI may accompany
psychomotor retardation in depression in older patients
and vice versa, it might have affected kinematic hand-
writing parameters in both groups to a similar extent. This
may have prevented a striking discrimination between
both MCI and DEP groups and AD patients. Depression
severity should be further addressed in future studies con-
trolled by the use of depression rating scales.
The concept of MCI describes cognitive deficits that
exceed normal physiological aging processes, but do not
fulfill the criteria for dementia. Longitudinal follow-up
studies showed a progressive decline from MCI to clini-
cally probable AD up to a rate of 15% per year [70–72].
Depression also seems to be associated with an increased
risk of incident dementia [73]. Therefore further longitu-
dinal evaluation of the clinical course and kinematic
handwriting parameters of patients with MCI and depres-
sion, including other types of dementia, e.g. LBD, is
required to appraise the predictive value of kinematic
handwriting analysis.
Longitudinal studies of hand-motor dysfunction in AD
patients will be clinically relevant because in order to
make therapeutic decisions it is important to know wheth-
er AD patients with motor disorders in an early stage of
disease have a poorer prognosis and a faster cognitive
decline than AD patients without these early signs of
motor dysfunction.
It is concluded that quantitative analysis of fine motor
functions is a useful tool for dementia research and looks
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promising for the important differential diagnosis be-
tween AD, MCI and depression.
AD and MCI patients differ from healthy subjects in
automation parameters and regularity of movement se-
quence.
AD and MCI patients reveal a typical fine motor pat-
tern: a decrease in automation with an unchanged peak
velocity.
Motor dysfunction quantified by kinematic handwrit-
ing analysis is significantly correlated to MMSE scores.
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